Skip to main content
Tech.euFundingExplorerBeta

Fresenius Medical Care Ventures

Investor profile

Venture capital

Fresenius Medical Care Ventures has backed 1 European tech company across 2 funding rounds between 2022 and 2023, joining rounds totalling €61M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
2
distinct rounds
Companies
1
backed
Active span
2022–2023
2 yrs
Total round €
€61M
sum of rounds joined

Deals by year

distinct rounds / year
Fresenius Medical Care Ventures — deals by year — interactive chart.
Data table
Fresenius Medical Care Ventures — deals by year
20221
20231

Top sectors

by deals
Fresenius Medical Care Ventures — top sectors — interactive chart.
Data table
Fresenius Medical Care Ventures — top sectors
Healthtech2

Stages

by deals
Fresenius Medical Care Ventures — stages — interactive chart.
Data table
Fresenius Medical Care Ventures — stages
Series B1
Series C1

Countries

by deals
Fresenius Medical Care Ventures — countries — interactive chart.
Data table
Fresenius Medical Care Ventures — countries
Switzerland2

Co-investment network

shared rounds
Co-investment network — interactive chart.
Fresenius Medical Care Ventures — 2 dealsFresenius Medical Care VenturesAdjuvant Capital — 2 shared deals · click to openAdjuvant CapitalGF Group Holding — 2 shared deals · click to openGF Group HoldingSwisscanto Invest — 2 shared deals · click to openSwisscanto InvestVerve Ventures — 2 shared deals · click to openVerve VenturesVesalius Biocapital Partners — 2 shared deals · click to openVesalius Biocapital PartnersPureos Bioventures — 1 shared deals · click to openPureos BioventuresRedalpine — 1 shared deals · click to openRedalpineSchroders Capital — 1 shared deals · click to openSchroders CapitalZürcher Kantonalbank — 1 shared deals · click to openZürcher Kantonalbank

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Memo TherapeuticsSwitzerland2€61M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Memo TherapeuticsSeries B€35M2022-02
Memo TherapeuticsSeries C€26M2023-11
← Back to investors